Consolidated Statements of Operations - USD ($)	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Revenue, net	$ 203,199	$ 30,504
Operating Expenses:
Research and development	61,431	897,277
General and administrative expenses	5,185,190	3,763,179
Total operating expenses	5,246,621	4,660,456
Loss from operations	(5,043,422)	(4,629,952)
Other income (expense)
Change in fair value of derivative liability		4,128
Loss on debt extinguishment		(15,076)
Loss on foreign currency exchange	(22,983)
Interest expense	(2,078)	(22,024)
Gain from legal settlements	1,290,059
Total other income (expense)	1,264,998	(32,972)
Loss before provision for income taxes	(3,778,424)	(4,662,924)
Provision for income taxes
Net Loss	$ (3,778,424)	$ (4,662,924)
Loss per common share:
Basic and diluted	$ (0.12)	$ (0.17)
Weighted average common shares outstanding:
Basic and diluted	31,298,976	27,820,791